TESOSLUP 2 | 1MG TESOFENSINE + 1MG SLU-PP-332 PER ML

TesoSLUP 2 is an innovative research-grade compound combining 1mg of Tesofensine and 1mg of SLU-PP-332 per mL in a convenient 30mL vial. This formulation is designed for scientific research and is not intended for human consumption. The dual combination of Tesofensine and SLU-PP-332 is being explored for its potential to support appetite suppression, fat loss, and metabolic enhancement, making it an exciting candidate in weight management and obesity studies.

TesoSLUP 2 Mechanism of Action in Research

TesoSLUP 2 combines two powerful compounds, Tesofensine and SLU-PP-332, both of which individually have shown promising results in weight loss and metabolic research. Together, these compounds may offer synergistic effects in the following areas:

Tesofensine: Appetite Suppression & Metabolic Enhancement

• Appetite Control: Tesofensine is a neurotransmitter reuptake inhibitor that affects dopamine, serotonin, and norepinephrine levels in the brain. By modulating these neurotransmitters, it may help reduce hunger and food cravings, making it beneficial for research into appetite regulation and weight loss protocols.
• Fat Loss Enhancement: In combination with other fat-burning agents, Tesofensine may support the breakdown of fat (lipolysis) and increase energy expenditure, potentially leading to fat loss and reduced body fat percentage.

SLU-PP-332: Metabolic Boosting & Fat Oxidation

• Metabolic Rate Boost: SLU-PP-332 is a synthetic peptide studied for its potential to increase fat oxidation and promote thermogenesis. It may support the body's natural fat-burning processes by improving metabolic efficiency and accelerating fat loss.
• Insulin Sensitivity Improvement: Research suggests that SLU-PP-332 may aid in enhancing insulin sensitivity, which is crucial for glucose metabolism and preventing fat accumulation, potentially improving overall metabolic health.

Research Applications

TesoSLUP 2 is being studied for several key applications, including:

✔ Appetite Control Studies: As a combination of two compounds with appetite-suppressing properties, TesoSLUP 2 is being explored in research focusing on obesity management and appetite regulation.

✔ Fat Loss & Weight Loss Research: The synergistic effects of Tesofensine and SLU-PP-332 may offer enhanced fat-burning and metabolic modulation, making this formulation ideal for studies on weight loss and fat reduction.

✔ Metabolic Enhancement Research: Researchers are investigating how this formulation may improve energy expenditure, boost metabolism, and enhance insulin sensitivity, contributing to overall metabolic health.

Packaging & Dosage Information

• Concentration: 1mg Tesofensine + 1mg SLU-PP-332 per mL
• Total Volume: 30mL per vial
• Recommended Dosage: As a research-grade compound, specific dosing protocols should be determined based on research guidelines and objectives. The product is not intended for human consumption.

Storage & Stability

• Store in a cool, dry place away from direct light.
• For long-term storage, freeze at -20°C for optimal stability and longevity.

Legal & Research Disclaimer

TesoSLUP 2 is for research purposes only and is not intended for human consumption. This product is meant for scientific and educational research only. It is not approved for medical or therapeutic use. Always adhere to research protocols and guidelines when utilizing this compound in laboratory settings.